Display options
Cite
Coletta M, Paroni M, Alvisi MF, et al. Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2021;doi: 10.1093/ecco-jcc/jjab107.
Coletta, M., Paroni, M., Alvisi, M. F., De Luca, M., Rulli, E., Mazza, S., Facciotti, F., Lattanzi, G., Strati, F., Abrignani, S., Claudio Fantini, M., Vecchi, M., Geginat, J., & Capriolia, F. (2021). Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjab107
Coletta, Marina, et al. "Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases." Journal of Crohn's & colitis vol. (2021). doi: https://doi.org/10.1093/ecco-jcc/jjab107
Coletta M, Paroni M, Alvisi MF, De Luca M, Rulli E, Mazza S, Facciotti F, Lattanzi G, Strati F, Abrignani S, Claudio Fantini M, Vecchi M, Geginat J, Capriolia F. Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2021 Nov 30; doi: 10.1093/ecco-jcc/jjab107. Epub 2021 Nov 30. PMID: 34850867.
Copy Download .nbib Format: NLM
Share it on

J Crohns Colitis. 2021 Nov 30; doi: 10.1093/ecco-jcc/jjab107. Epub 2021 Nov 30.

Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.

Journal of Crohn's & colitis

Marina Coletta, Moira Paroni, Maria Francesca Alvisi, Matilde De Luca, Eliana Rulli, Stefano Mazza, Federica Facciotti, Georgia Lattanzi, Francesco Strati, Sergio Abrignani, Massimo Claudio Fantini, Maurizio Vecchi, Jens Geginat, Flavio Capriolia

Affiliations

  1. Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  2. Istituto Nazionale di Genetica Molecolare 'Enrica ed Romeo Invernizzi' [INGM], Milan, Italy.
  3. Department of Biosciences, Università degli Studi di Milano, Milan, Italy.
  4. Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  5. Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  6. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  7. Department of Systems Medicine, Università di Roma Tor Vergata, Rome, Italy.
  8. Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

PMID: 34850867 DOI: 10.1093/ecco-jcc/jjab107

[No abstract available.]

Publication Types